Loading
companiesCompany
HUB Organoids
The Clevers-lab spin-out that licenses patient-derived organoid technology and maintains a living biobank.
Overview
HUB Organoids, based in Utrecht, is the spin-out from the Clevers laboratory that licenses patient-derived organoid technology and maintains a living biobank. It offers an organoid biobank and services to pharmaceutical companies and is the licensor of the foundational organoid patents. OnCo links it to biobanking and tissue procurement, patient-derived organoids and the organoid term. Whether patent licensing helps or slows the spread of organoid methods into routine drug testing is the fair question. The organoid technology page carries the evidence.
Similar pages
- CompanyIndivumed
Shares Biobanking and tissue procurement and the tag supporting.
- CompanyDiscovery Life Sciences
Shares Biobanking and tissue procurement and the tag supporting.
- TechnologyPre-analytics: blood-collection tubes and tissue fixation
Shares Biobanking and tissue procurement and the tag supporting.
- TechnologyStructural biology infrastructure (cryo-EM, synchrotrons, AlphaFold)
Shares Drug discovery roadmap: screening in mice → maps of dependency → designing in silico and the tag supporting.
- TechnologyHigh-throughput screening and DNA-encoded libraries
Shares Drug discovery roadmap: screening in mice → maps of dependency → designing in silico and the tag supporting.
- IdeaLinked human organ chips to predict side effects before people are dosed
Shares Drug discovery roadmap: screening in mice → maps of dependency → designing in silico, Patient-derived organoids.
- IdeaShared reference organoid and PDX panels that every lab can test against
Shares Drug discovery roadmap: screening in mice → maps of dependency → designing in silico, Patient-derived organoids.
- TermIn vitro and in vivo
Shares Organoid, Patient-derived organoids.